Cerebrovascular disease
Conditions
Interventions
The standard schedule for this study is to complete 27 treatment programs (described below) in 4 weeks. In this study, ESPURGE (manufactured by Ito Ultra-shortwave Co., Ltd.) is used. 1) Forward s
Sponsors
International University of Health and Welfare Graduate School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who can obtain consent to participate in research by voluntary intention in writing. If the patient has the ability to consent but writing is difficult due to disability, etc., confirm that the patient has agreed to participate in the study, and obtain consent from the family or key person . (2) Patients whose age at the time of obtaining consent is between 20 and 90 years old. (3) Patients with stroke recovery (within 6 months [180 days] from the onset of stroke). (4) Patients who have not had paralysis on the same side as the present onset. (5) Patients with upper extremities and fingers I-II at the Brunnstrom Recovery Stage (BRS). (6) Patients with stable general condition such as blood pressure, pulse and blood glucose level.
Exclusion criteria
Exclusion criteria: (1) Patients whose upper limb function training is judged to be difficult due to dyspnea during work, heart failure, arrhythmia, or myocardial infarction. (2) Patients with a history of neurological disorders or upper limb joint diseases that affect upper limb function. (3) Patients who have advanced complications such as degenerative shoulder and elbow arthritis, poorly controlled rheumatoid arthritis, scoliosis, osteoporosis, etc., and upper limb function training is difficult or symptoms are worsened by upper limb training. (4) Patients with severe liver disorder, renal disorder, cardiovascular disease. (5) Patients with higher brain dysfunction such as severe consciousness disorder, sensory disturbance or ataxia, aphasia (6) Contraindication examples of electrical stimulation therapy. Using implantable electronic devices (such as pacemakers), patients with heart disease, malignant tumor, tuberculosis disease, or acute disease, extremely weak, pregnant or possibly pregnant, using metal implants Who is. Other persons deemed inappropriate by doctors. A person with abnormal blood pressure, fever, or infectious disease. (7) Patients who cannot apply electrode pads due to skin diseases. (8) Patients who need other treatments that affect the study due to fractures, trauma and other diseases at the time of obtaining consent. (9) Those deemed to be maladapted by doctors when participating in this study When an appropriate response to electrical stimulation cannot be obtained. When significant improvement in upper limb function is observed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Automatic motion angle of shoulder joint by two-dimensional motion analysis (2)Muscle activity of the anterior deltoid muscle, triceps, and extensor extensor muscles by surface electromyography Measure on the day before treatment, immediately before and after treatment, and the next day after treatment program | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Stroke Impairment Assessment Set (SIAS) (2) Upper extremities, fingers Brunnstrom Recovery Stage (BRS) (3) Upper limb Fugl-Meyer Assessment (FMA) (4) Manual Function Test (MFT) (5) Number of grips (6) Modified Ashworth scale (MAS) (7) Jikei Assessment Scale for Motor Impairment in Daily Living (JASMID) (8) Functional independence Measure (FIM) (9) Barthel Index (BI) Measure on the day before the treatment, the second week of treatment (the 14th day), and the day after the treatment program | — |
Countries
Japan
Contacts
Public Contactryuji sugawara
International University of Health and Welfare Graduate School Department of Occupational Therapy, Department of Health Sciences
Outcome results
None listed